|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D07.5 |
Carcinoma in situ of prostate
Diagnosis Valid for Male Patient Only
|
D075 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 27.10%
|
23.24%
|
16.27%
|
9.67%
|
6.22%
|
3.21%
|
4.24%
|
2.47%
|
1.94%
|
1.64%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D07.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
649
|
652
|
|
84153
|
ASSAY OF PSA TOTAL |
605
|
605
|
|
80053
|
COMPREHEN METABOLIC PANEL |
252
|
252
|
|
55700
|
BIOPSY OF PROSTATE |
233
|
233
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
232
|
1,025
|
|
G0416
|
PROSTATE BIOPSY, ANY MTHD |
202
|
213
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
201
|
201
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
169
|
4,802
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
168
|
264
|
|
88344
|
IMHCHEM/IMCYTCHM EA MLT ANTB |
165
|
292
|
|
80061
|
LIPID PANEL |
158
|
158
|
|
J3010
|
FENTANYL CITRATE INJECTION |
131
|
193
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
114
|
114
|
|
97110
|
THERAPEUTIC EXERCISES |
111
|
201
|
|
84443
|
ASSAY THYROID STIM HORMONE |
107
|
107
|
|
76942
|
ECHO GUIDE FOR BIOPSY |
107
|
107
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
105
|
240
|
|
80048
|
METABOLIC PANEL TOTAL CA |
100
|
100
|
|
J2405
|
ONDANSETRON HCL INJECTION |
99
|
410
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
88
|
88
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D07.5 related to the following DRG Codes:
715-716
722-724
|
